Author

Kelley C. Larson

Observed names: Kelley Larson, Larson, Kelley C.

Observed institutions: Galenea (United States), Paratek Pharmaceuticals (United States), Watertown City School District

OpenAlex ID: A5000512406

Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy

2009 · Michelle L. Hastings, Joel Berniac, et al. · Science Translational Medicine · 87

Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2

2009 · Kelley C. Larson, Michael P. Draper, et al. · Inflammation Research · 44

Rescue of in vitro models of CSF1R-related adult-onset leukodystrophy by iluzanebart: mechanisms and therapeutic implications of TREM2 agonism

2025 · Kelley C. Larson, Frederick W. Gergits, et al. · Journal of Neuroinflammation · 13

In Vitro and In Vivo Antimalarial Efficacies of Optimized Tetracyclines

2013 · Michael P. Draper, Beena Bhatia, et al. · Antimicrobial Agents and Chemotherapy · 11

Pharmacological and functional characterization of the first small molecule TREM2 agonist, VG‐3927, for the treatment of Alzheimer’s disease

2024 · Christian Mirescu, Borislav Dejanovic, et al. · Alzheimer s & Dementia · 10

Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease

2024 · Kelley C. Larson, Lauren H. Martens, et al. · Journal of Neuroinflammation · 8

Development of a High-Throughput AlphaScreen Assay for Modulators of Synapsin I Phosphorylation in Primary Neurons

2013 · Betty Chan, Jeffrey R. Cottrell, et al. · SLAS DISCOVERY · 6

VGL101 Rescues CSF1R Dysfunction in Human Microglia And Macrophages: Evaluation of In Vitro Trem2 Agonism in Models Of A CSF1R‐Dependent Leukodystrophy

2022 · Kelley C. Larson, Frederick Gergits, et al. · Alzheimer s & Dementia · 5

Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2

2009 · Kelley C. Larson, Maciej Lipko, et al. · Inflammation Research · 2

VGL101: An Immunotherapy that Enhances Microglial Survival for Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) (P9-9.013)

2024 · Kelley C. Larson, Frederick W. Gergits, et al. · Neurology · 1

P3‐055: Systems Biology Platform to Enable Neuroinflammatory Target Id, Validation, and Patient Selection for Disease‐modifying Alzheimer's Disease Therapeutics

2019 · Thomas A. Miller, Lauren H. Martens, et al. · Alzheimer s & Dementia

Comparative Analysis of Yeast Expression Profiles Using an Annotated Microarray Database

2003 · Kelley Larson, Jennifer Marcello, et al.

Works count: 17

Citation count: 187

H-index: 6

I10-index: 5